This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cain, A. E. Articles by Khalil, R. A. Search for Related Content PubMed PubMed Citation Articles by Cain, A. E. Articles by Khalil, R. A. Related Collections Calcium cycling/excitation-contraction coupling Cell biology/structural biology Cell signalling/signal transduction Ischemic biology - basic studies Ion channels/membrane transport Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Chronic ischemic heart disease Coronary circulation Other Vascular biology

(Hypertension. 2002;39:543.)
© 2002 American Heart Association, Inc.

Scientific Contributions

Endothelin-1–Induced Enhancement of Coronary Smooth Muscle Contraction via MAPK-Dependent and MAPK-Independent [Ca²⁺]_i Sensitization Pathways

Ashley E. Cain; Dennis M. Tanner; Raouf A. Khalil

From the Department of Physiology and Biophysics and, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Miss.

Correspondence to Raouf A. Khalil, MD, PhD, Department of Physiology & Biophysics, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216. E-mail rkhalil{at}physiology.umsmed.edu

Endothelin-1 (ET-1) has been implicated in coronary vasospasm by enhancing coronary vasoconstriction to vasoactive eicosanoids, and a role for protein kinase C (PKC) activation has been suggested. However, the cellular mechanisms downstream from PKC activation are unclear. We investigated whether physiological concentrations of ET-1 enhance coronary smooth muscle contraction by activating a PKC-mediated signaling pathway involving tyrosine phosphorylation and activation of mitogen-activated protein kinase (MAPK). Cell contraction was measured in smooth muscle cells isolated from porcine coronary artery, [Ca²⁺]_i was measured in fura-2 loaded cells, and tissue fractions were examined for reactivity with anti-phosphotyrosine (P-Tyr) and anti-MAPK antibodies using immunoprecipitation and immunoblot analysis. In Hanks’ solution (1 mmol/L Ca²⁺), ET-1 (10 pmol/L) did not increase basal [Ca²⁺]_i (81±2 nmol/L) but caused cell contraction (10%) that was inhibited by calphostin C (10^-6 mol/L), inhibitor of PKC, tyrphostin (10^-6 mol/L), inhibitor of tyrosine kinase, and PD098059 (10^-6 mol/L), inhibitor of MAPK kinase. The vasoactive eicosanoid prostaglandin F₂ (PGF₂; 10^-7 mol/L) caused increases in cell contraction (11%) and [Ca²⁺]_i (122±9 nmol/L) that were inhibited by the Ca²⁺ channel blocker verapamil (10^-6 mol/L) but not by calphostin C, tyrphostin, or PD098059. Pretreatment with ET-1 for 10 minutes enhanced cell contraction to PGF₂ (33%) with no additional increase in [Ca²⁺]_i (124±10 nmol/L). Activation of PKC by phorbol 12-myristate 13-acetate (PMA; 10^-7 mol/L) caused cell contraction and enhanced PGF₂ contraction (32%) with no additional increase in [Ca²⁺]_i (126±9 nmol/L). The ET-1– and PMA-induced enhancement of PGF₂ contraction was abolished by verapamil or calphostin C but not by tyrphostin or PD098059. ET-1 and PMA caused significant increases in tyrosine phosphorylation of MAPK that were inhibited by calphostin C, tyrphostin, and PD098059. PGF₂ did not cause any additional increases in tyrosine phosphorylation of MAPK in tissues untreated or pretreated with ET-1 or PMA. Thus, physiological concentrations of ET-1 activate a Ca²⁺-independent PKC-mediated signaling pathway that involves tyrosine phosphorylation and activation of MAPK. The enhancement of PGF₂-induced coronary smooth muscle contraction by ET-1 involves additional activation of a Ca²⁺-sensitive PKC-mediated pathway but not tyrosine phosphorylation or activation of MAPK. The MAPK-dependent and MAPK-independent signaling pathways represent possible cellular mechanisms by which ET-1 could enhance coronary vasoconstriction to vasoactive eicosanoids in coronary vasospasm.

Key Words: endothelin • prostaglandins • calcium • protein kinases • muscle, smooth, vascular

This article has been cited by other articles:

				B. Ponnuchamy and R. A. Khalil Cellular mediators of renal vascular dysfunction in hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1001 - R1018. [Abstract] [Full Text] [PDF]

				C. Dubroca, D. You, B. I. Levy, L. Loufrani, and D. Henrion Involvement of RhoA/Rho Kinase Pathway in Myogenic Tone in the Rabbit Facial Vein Hypertension, May 1, 2005; 45(5): 974 - 979. [Abstract] [Full Text] [PDF]

				B. Kim, J. Kim, Y. M. Bae, S. I. Cho, S. C. Kwon, J. Y Jung, J.-C. Park, and H. Y. Ahn p38 Mitogen-Activated Protein Kinase Contributes to the Diminished Aortic Contraction by Endothelin-1 in DOCA-Salt Hypertensive Rats Hypertension, May 1, 2004; 43(5): 1086 - 1091. [Abstract] [Full Text] [PDF]

				T. A. Khan, C. Bianchi, M. Ruel, P. Voisine, and F. W. Sellke Mitogen-activated protein kinase pathways and cardiac surgery J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 806 - 811. [Abstract] [Full Text] [PDF]

				H. M. ROSENFELDT, Y. AMRANI, K. R. WATTERSON, K. S. MURTHY, R. A. PANETTIERI JR, and S. SPIEGEL Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells FASEB J, October 1, 2003; 17(13): 1789 - 1799. [Abstract] [Full Text] [PDF]

				T. A. Khan, C. Bianchi, M. Ruel, P. Voisine, J. Li, J. R. Liddicoat, and F. W. Sellke Mitogen-Activated Protein Kinase Inhibition and Cardioplegia-Cardiopulmonary Bypass Reduce Coronary Myogenic Tone Circulation, September 9, 2003; 108(90101): II-348 - 353. [Abstract] [Full Text] [PDF]

				S. Pikkarainen, H. Tokola, R. Kerkela, T. Majalahti-Palviainen, O. Vuolteenaho, and H. Ruskoaho Endothelin-1-specific Activation of B-type Natriuretic Peptide Gene via p38 Mitogen-activated Protein Kinase and Nuclear ETS Factors J. Biol. Chem., January 31, 2003; 278(6): 3969 - 3975. [Abstract] [Full Text] [PDF]

				M. P. Massett, Z. Ungvari, A. Csiszar, G. Kaley, and A. Koller Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2282 - H2287. [Abstract] [Full Text] [PDF]

				R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 213 - 225. [Abstract] [PDF]